Home > News > Nanoscale “Cell Within A Cell”
August 1st, 2005
Nanoscale “Cell Within A Cell”
Abstract:
Imagine a cancer drug that can burrow into a tumor, seal the exits and detonate a lethal dose of anticancer toxins, all while leaving healthy cells unscathed. Investigators at the Massachusetts Institute of Technology have designed a multifunctional nanoparticle to do just that. The dual-chamber, double-acting, drug-packing "nanocell" proved effective and safe, with prolonged survival, against two distinct forms of cancers-melanoma and Lewis lung cancer-in mice. This work, conducted by a multidisciplinary team led by Ram Sasisekharan, Ph.D., of MIT, was published in the journal Nature.
The nanocell worked better against melanoma than lung cancer, indicating the need to tweak the design for different cancers. "This model enables us to rationally and systematically evaluate drug combinations and loading mechanisms," says Dr. Sasisekharan. "It's not going to stop here. We want to build on this concept."
Source:
nano.cancer.gov
Bookmark:
| Related Links |
Massachusetts Institute of Technology
| Related News Press |
Possible Futures
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||